Total Payments
$13,450
2024 Payments
$120.23
Companies
51
Transactions
724
Medicare Patients
14,073
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$12,794 (95.1%)
Education$656.01 (4.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,794 | 703 | 95.1% |
| Education | $656.01 | 21 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,240 | 77 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $858.53 | 49 | $0 (2021) |
| Celgene Corporation | $822.05 | 40 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $703.07 | 44 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $603.09 | 44 | $0 (2022) |
| GENZYME CORPORATION | $551.09 | 19 | $0 (2022) |
| Seagen Inc. | $544.20 | 28 | $0 (2022) |
| PFIZER INC. | $515.52 | 35 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $494.06 | 28 | $0 (2021) |
| Pharmacyclics LLC, An AbbVie Company | $488.98 | 22 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $120.23 | 7 | Novartis Pharmaceuticals Corporation ($104.50) |
| 2023 | $217.02 | 11 | Celgene Corporation ($145.29) |
| 2022 | $1,745 | 88 | Seagen Inc. ($194.04) |
| 2021 | $2,183 | 99 | GENZYME CORPORATION ($296.10) |
| 2020 | $1,400 | 75 | Amgen Inc. ($139.46) |
| 2019 | $2,633 | 137 | Janssen Biotech, Inc. ($424.16) |
| 2018 | $3,274 | 201 | AstraZeneca Pharmaceuticals LP ($484.96) |
| 2017 | $1,878 | 106 | E.R. Squibb & Sons, L.L.C. ($217.78) |
All Payment Transactions
724 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/06/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Oncology | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Oncology | ||||||
| 07/22/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Oncology | ||||||
| 06/07/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Oncology | ||||||
| 04/12/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug), LUTATHERA | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Oncology | ||||||
| 02/05/2024 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $15.73 | General |
| Category: Hematology | ||||||
| 01/19/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug), PLUVICTO | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Oncology | ||||||
| 10/27/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $24.15 | General |
| Category: Hematology | ||||||
| 09/25/2023 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug), PLUVICTO | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Oncology | ||||||
| 09/19/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $18.88 | General |
| Category: Hematology | ||||||
| 07/17/2023 | Celgene Corporation | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $20.86 | General |
| Category: Oncology | ||||||
| 06/20/2023 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug), PLUVICTO | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Oncology | ||||||
| 06/08/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: ONCOLOGY | ||||||
| 05/30/2023 | Celgene Corporation | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $21.27 | General |
| Category: Oncology | ||||||
| 04/26/2023 | Celgene Corporation | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $20.15 | General |
| Category: Oncology | ||||||
| 02/13/2023 | Celgene Corporation | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $22.02 | General |
| Category: Oncology | ||||||
| 01/31/2023 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Oncology | ||||||
| 01/11/2023 | Celgene Corporation | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $17.96 | General |
| Category: Oncology | ||||||
| 12/22/2022 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $32.91 | General |
| Category: Oncology | ||||||
| 12/21/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: ONCOLOGY | ||||||
| 12/20/2022 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $15.98 | General |
| 12/19/2022 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Oncology | ||||||
| 12/07/2022 | Kyowa Kirin, Inc. | POTELIGEO (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Monoclonal Antibody | ||||||
| 12/07/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.31 | General |
| Category: Oncology | ||||||
| 12/06/2022 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $35.82 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 366 | 817 | $373,401 | $67,881 |
| 2022 | 50 | 4,002 | 16,371 | $1.2M | $308,333 |
| 2021 | 56 | 4,634 | 18,949 | $1.3M | $406,515 |
| 2020 | 61 | 5,071 | 20,680 | $1.2M | $411,822 |
Total Patients
14,073
Total Services
56,817
Medicare Billing
$1.2M
Procedure Codes
178
All Medicare Procedures & Services
178 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 83 | 83 | $90,055 | $17,163 | 19.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 137 | $79,049 | $16,728 | 21.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 55 | 161 | $61,663 | $11,489 | 18.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 43 | 45 | $48,015 | $7,038 | 14.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $39,015 | $6,645 | 17.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 26 | $20,098 | $4,423 | 22.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 11 | 11 | $11,935 | $1,797 | 15.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 11 | 12 | $2,196 | $1,462 | 66.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 45 | $6,255 | $630.00 | 10.1% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2023 | 12 | 252 | $15,120 | $507.97 | 3.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 302 | 746 | $303,766 | $73,106 | 24.1% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2022 | 30 | 43 | $218,956 | $59,787 | 27.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 91 | 532 | $79,800 | $24,307 | 30.5% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2022 | 38 | 92 | $14,720 | $14,696 | 99.8% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2022 | 30 | 44 | $47,388 | $12,725 | 26.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 303 | 1,628 | $45,584 | $12,485 | 27.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 298 | 1,190 | $59,500 | $12,410 | 20.9% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2022 | 298 | 1,460 | $32,120 | $8,702 | 27.1% |
| 83735 | Magnesium level | Office | 2022 | 250 | 1,304 | $31,296 | $8,626 | 27.6% |
| 82728 | Ferritin (blood protein) level | Office | 2022 | 237 | 592 | $29,008 | $7,963 | 27.5% |
| 84466 | Transferrin (iron binding protein) level | Office | 2022 | 237 | 591 | $27,186 | $7,440 | 27.4% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2022 | 19 | 24 | $25,776 | $6,608 | 25.6% |
| 84550 | Uric acid level, blood | Office | 2022 | 297 | 1,455 | $23,280 | $6,488 | 27.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 36 | $20,484 | $5,057 | 24.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 25 | 25 | $17,110 | $3,938 | 23.0% |
About Dr. Pradip Rustagi, MD
Dr. Pradip Rustagi, MD is a Hematology & Oncology healthcare provider based in Bend, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881709699.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pradip Rustagi, MD has received a total of $13,450 in payments from pharmaceutical and medical device companies, with $120.23 received in 2024. These payments were reported across 724 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($12,794).
As a Medicare-enrolled provider, Rustagi has provided services to 14,073 Medicare beneficiaries, totaling 56,817 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 178 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Bend, OR
- Active Since 08/20/2006
- Last Updated 01/18/2023
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1881709699
Products in Payments
- IMBRUVICA (Drug) $705.55
- ZEJULA (Drug) $610.68
- OPDIVO (Biological) $514.07
- BENDEKA (Drug) $473.53
- ADCETRIS (Biological) $465.89
- DARZALEX (Biological) $461.98
- TAGRISSO (Drug) $443.85
- PROVENGE (Drug) $428.70
- SARCLISA (Biological) $392.01
- Cabometyx (Drug) $326.43
- Zevalin (Drug) $294.31
- Revlimid (Drug) $275.64
- TUKYSA (Drug) $273.26
- FASLODEX (Drug) $273.05
- Imbruvica (Drug) $252.72
- KEYTRUDA (Biological) $246.34
- AFINITOR (Drug) $225.26
- JAKAFI (Drug) $212.89
- CYRAMZA (Drug) $192.03
- FERAHEME (Drug) $185.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Bend
Hyung-Chil Kang, M.d, M.D
Hematology & Oncology — Payments: $26,936
Hematology & Oncology $26,936
Dr. Natasha Tiffany, M.d, M.D
Hematology & Oncology — Payments: $18,544
Hematology & Oncology $18,544
Dr. Andrew Chen, D.o, D.O
Hematology & Oncology — Payments: $11,691
Hematology & Oncology $11,691
Dr. Christina Fitzmaurice, M.d, M.D
Hematology & Oncology — Payments: $1,141
Hematology & Oncology $1,141
Dr. Richard Reed, Md, MD
Hematology & Oncology — Payments: $568.67
Hematology & Oncology $568.67
Bryden Considine, Do, DO
Hematology & Oncology — Payments: $483.78
Hematology & Oncology $483.78